Gene Query: NSMAF

Dataset Description Geneva Score
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 58.6
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 58.6
Total RNA-seq in ALL-SIL upon JQ1 inhibition 39.92
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 39.69
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 39.69
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 38.52
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 28.83
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 26.21
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 26.21
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 24.75
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 24.75
LNCaP treated with iBET 22.56
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 22.01
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 21.36
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 21.07
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 20.58
Human neutrophil genome during PMA- and E. coli encounter-induced activation 20.58
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 19.72
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 19.45
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 18.07
AMPK signaling for naïve pluripotency 17.08
AMPK signaling for naïve pluripotency [Hs] 17.08
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 16.03
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 15.99
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 15.99
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 15.96
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 15.16
RNA-seq of YB5 cells treated with Proscillaridin A 14.78
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 14.09
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.06
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 13.94
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 13.94
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 13.8
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 13.8
Loss of CREBBP results in gene expression repression in lymphoma cells 13.46
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 13.46
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 12.93
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 12.45
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 12.28
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 12.18
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.15
Depicting early human development and germ cell origin with porcine embryos 12.05
Tumor exosome integrins determine organotropic metastasis 11.97
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 11.93
Functional role of SLIT2 and ROBO1 in trophoblasts 11.74
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 11.7
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.62
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 11.59
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.58
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 11.53
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.46
IDH3a KO RNA-seq 11.44
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 11.41
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 11.19
The comparison of high-throughput single-cell RNA-seq methods 11.08
RNA sequencing of human mammary epithelial cells 11.04
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 10.86
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.74
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.74
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 10.73
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 10.66
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 10.62
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.56
RNA-seq analysis of AML cells in response to ASLAN003 10.46
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 10.43
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.27
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.05
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.05
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.81
Knockdown of ADNP in HCT116 colon cancer cells 9.79
Genome-wide analysis of the Integrator complex 9.74
Genome-wide analysis of the Integrator complex (HTS) 9.74
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 9.57
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 9.54
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 9.51
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 9.38
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 9.33
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 9.24
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.2
Developmental stage specific chromosome architecture in human erythroid cells 9.12
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.12
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.98
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.98
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.97
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.97
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 8.94
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 8.94
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.93
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 8.86
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.86
Transcriptome of diurnal human blood neutrophils 8.78
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 8.78
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 8.74
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 8.74
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.61
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 8.55
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.49
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 8.48
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 8.45
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 8.43
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 8.43
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 8.36
Regionally specified human pluripotent stem cell-derived astrocytes 8.36
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.34
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 8.26
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 8.23
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 8.23
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 8.21
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 8.2
Efficient derivation of microglia-like cells from human pluripotent stem cells 8.15
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 8.13
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 8.12
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.1
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.1
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.08
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 8.01
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 8.0
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 7.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 7.98
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 7.98
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 7.96
Identification of global regulators of T-helper cell lineage specification 7.96
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 7.87
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 7.83
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.79
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 7.77
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 7.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.69
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.69
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.69
SRSF2 mutations impair hematopoiesis and alter exon recognition 7.65
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 7.6
Pharmacologic inhibition of STAT5 in AML 7.6
Rorc disruption in human FG pancreatic cancer cells 7.56
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.55
Human Treg NaCl stimulation 7.5
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 7.38
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.34
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 7.29
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 7.29
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 7.28
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 7.26
RNA sequencing of primary human platelets and in vitro cell lines 7.22
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 7.17
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.16
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 7.15
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 7.05
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.01
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 6.99
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 6.97
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.97
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 6.96
A549 cells and MSR-A549 cells 6.95
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.95
Nutritional control of protein translation 6.91
Identification of long noncoding RNAs regulated by p53 6.89
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 6.87
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.81
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 6.78
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.78
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.78
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.76
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 6.72
RNA-seq of young and quiescent MRC-5 human fibroblasts 6.71
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.71
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.69
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 6.67
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 6.67
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 6.67
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 6.67
Gene expression profile in breast cancer cells 6.67
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.64
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.62
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 6.61
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.61
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 6.6
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 6.6
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 6.6
Genome-wide discovery of human splicing branchpoints 6.57
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 6.57
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 6.55
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 6.55
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 6.54
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 6.52
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 6.52
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.48
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.48
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 6.48
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.47
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 6.45
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 6.43
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.42
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.42
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 6.41
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 6.41
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 6.4
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.37
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.3
RNAseq of T-ALL upon long non coding rna purturbation 6.28
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.28
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.28
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.18
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 6.13
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 6.1
Accurate annotation of human protein-coding small open reading frames 6.09
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 6.06
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.0
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.99
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.97
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.96
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 5.94
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.93
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 5.92
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.91
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 5.88
KSDM1b Role in Ewing Sarcoma 5.87
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 5.86
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 5.86
MYC dependent mRNA translation shapes gene expression and cell biology 5.81
A map of gene expression in neutrophil-like cell lines 5.8
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 5.79
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.78
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.78
RNAseq Study in CC-671 Treated Cal-51 Cells 5.76
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.71
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.71
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.71
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.7
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.69
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.69
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.68
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.66
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 5.63
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.6
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.57
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.53
TCF7L1 knockdown in pancreatic cancer 5.52
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.44
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.44
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 5.43
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 5.43
6mer seed toxicity in tumour suppressive microRNAs 5.43
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 5.41
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.37
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 5.37
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 5.37
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 5.36
SUV420H2 knockdown in PANC-1 5.28
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.28
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.27
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.27
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.23
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 5.22
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.16
RNA-seq of RKO cells with cTAZ KO or putback 5.14
AUF-1 affected genes in human skin cells 5.06
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.01
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 4.96
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.96
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.96
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 4.9
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 4.9
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.87
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.86
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 4.83
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.82
Hypoxic transcriptome of SQ20B human head and neck cancer cells 4.75
RNA-seq of cells with TET1 knockout 4.71
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.69
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.69
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.66
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.64
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.64
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.63
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.6
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.59
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.59
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.51
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.51
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.5
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.5
Gene expression changes upon drug withdrawal (Mel888 cell line) 4.49
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 4.47
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 4.42
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.34
Gene expression signatures of innate lymphoid cells from human blood 4.3
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.28
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 4.27
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.25
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.25
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 4.23
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 4.23
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.23
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.23
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.22
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 4.21
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 4.21
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.2
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.2
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 4.18
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 4.17
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.15
Effect of PRDM11 depletion in U2932 cells 4.08
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.07
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.07
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.07
Effects of rFVIIIFc on human macrophages 4.06
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.05
Analysis of transcriptional regulation by Myt1 and Myt1l 3.99
Transcriptome analysis of peripheral blood monocytes 3.97
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.97
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.97
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.95
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.92
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.92
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.91
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.9
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.89
RNA expression analysis upon JMJD1C depletion 3.89
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.89
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.89
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 3.88
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 3.83
Trascriptome of thyroid cancer-induced macrophages 3.79
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.75
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.7
NHLRC1 re-expression in cancer cells 3.64
Transcriptome wide analysis of classically and alternatively activated macrophages 3.63
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.62
AR-independent prostate cancer is sustained through FGF signaling 3.6
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.58
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.58
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.58
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.53
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.44
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.39
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.39
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 3.3
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.28
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.27
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.26
Copper Regulation of HIF-1 Transcription Activity 3.26
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.26
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.18
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.15
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.15
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.12
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.07
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.98
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.97
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 2.93
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.91
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.91
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.89
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.83
NAPRT activation of macrophages 2.75
Transcriptome analysis of CNS leukemia 2.72
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.72
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.7
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.62
Human Treg IFNg/IL-10 subpopulations 2.61
Functional significance of the HIV-1 Tat signature amino acid residues 2.59
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 2.56
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.55
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.5
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.45
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.45
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.41
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 2.4
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.35
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.33
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.31
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.3
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 2.28
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.26
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.17
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.15
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.15
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.14
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.09
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.09
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.07
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.05
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.05
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 2.03
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.98
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.98
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.98
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.98
miR-93 Targets in Human Endothelial Cells 1.95
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.92
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.92
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.89
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.87
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.84
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.82
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 1.81
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.8
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.8
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.75
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.72
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.7
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.67
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.66
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.66
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 1.65
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.64
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.58
The circadian transcriptional landscape in primary human mammary epithelial cells 1.58
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.55
Impact on erythroid progenitor type on erythroid differntiation 1.47
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.47
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.37
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.37
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.29
SOX11 knockdown in B-ALL cell lines 1.28
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.28
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.26
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.26
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.24
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.23
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.23
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.2
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.19
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.19
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.18
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.16
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.15
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.14
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.13
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.13
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.12
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.11
Downregulation of LATS kinases alters p53 to promote cell migration 1.08
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.07
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.07
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.05
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.04
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.04
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.03
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.99
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.99
IMP3 regulated gene expression in breast cancer cells 0.98
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.97
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.88
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.88
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.84
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.84
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.84
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.83
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.81
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.81
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.81
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.81
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.8
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.76
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.76
Finding missing proteins from epigenetically manipulated human cells 0.74
RNA-seq of primary patient AML samples 0.71
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.6
Reprogrammed myeloid cell transcriptomes in NSCLC 0.59
siRNA-mediated knockdown 0.58
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.52
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.49
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.49
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.48
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.48
Tpl-2 small molecule project 0.47
Tpl-2 and MEK small molecule inhibitors 0.47
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.44
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.42
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.41
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 0.4
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.34
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.33
Function and hormonal regulation of GATA3 in human first trimester placentation 0.3
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.29
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.29
Direct Isolation and Characterization of Human Nephron Progenitors. 0.28
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.21
Macrophage Ad5f35 M2 Challenge 0.18
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.15
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.15
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.14
Leucegene: AML sequencing (part 6) 0.13
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.1
Targeting MTHFD2 in Acute Myeloid Leukemia 0.07
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.06
N6-methyladenine DNA Modification in Glioblastoma 0.06
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.0
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.0
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation